HK1208029A1 - Imidazopyridine derivatives - Google Patents

Imidazopyridine derivatives

Info

Publication number: HK1208029A1
Authority: HK; Hong Kong
Prior art keywords: imidazopyridine derivatives; imidazopyridine; derivatives
Prior art date: 2012-11-29

Application number

HK15108708.9A

Other languages

English (en)

Chinese (zh)

Inventor

西蒙娜．

．切卡雷利

拉維．姚高希亞

羅蘭．雅各布-勒特

于爾根．維希曼

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-11-29

Filing date

2015-09-08

Publication date

2016-02-19

2015-09-08 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2016-02-19 Publication of HK1208029A1 publication Critical patent/HK1208029A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HK15108708.9A 2012-11-29 2015-09-08 Imidazopyridine derivatives HK1208029A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12194721		2012-11-29
PCT/EP2013/074662 WO2014082979A1 (en)	2012-11-29	2013-11-26	Imidazopyridine derivatives

Publications (1)

Publication Number	Publication Date
HK1208029A1 true HK1208029A1 (en)	2016-02-19

Family

ID=47263164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK15108708.9A HK1208029A1 (en)	2012-11-29	2015-09-08	Imidazopyridine derivatives

Country Status (11)

Country	Link
US (1)	US9315502B2 (xx)
EP (1)	EP2925756B1 (xx)
JP (1)	JP6007339B2 (xx)
KR (1)	KR101735975B1 (xx)
CN (1)	CN104822679B (xx)
BR (1)	BR112015008200A2 (xx)
CA (1)	CA2884956A1 (xx)
HK (1)	HK1208029A1 (xx)
MX (1)	MX2015006513A (xx)
RU (1)	RU2644949C2 (xx)
WO (1)	WO2014082979A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012177647A2 (en)	2011-06-20	2012-12-27	Kerry Lane	Mycotoxin diagnostics and methods thereof
WO2015200341A1 (en) *	2014-06-23	2015-12-30	Dr. Reddy's Laboratories Ltd.	Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
WO2018013430A2 (en)	2016-07-12	2018-01-18	Arisan Therapeutics Inc.	Heterocyclic compounds for the treatment of arenavirus infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002002557A2 (en) *	2000-06-30	2002-01-10	Neurogen Corporation	2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
DOP2006000051A (es) *	2005-02-24	2006-08-31	Lilly Co Eli	Inhibidores de vegf-r2 y métodos
EP1861095A1 (en) *	2005-03-24	2007-12-05	Glaxo Group Limited	Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases
KR101062583B1 (ko) *	2006-01-17	2011-09-06	에프. 호프만-라 로슈 아게	Ｇａｂａ 수용체에 의해 알츠하이머병의 치료에 유용한아릴-아이속사졸-4-일-이미다조[1,2-ａ]피리딘
WO2008016123A1 (fr) *	2006-08-03	2008-02-07	Takeda Pharmaceutical Company Limited	INHIBITEUR DE LA GSK-3β
FR2906250B1 (fr) *	2006-09-22	2008-10-31	Sanofi Aventis Sa	Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
CN101679408B (zh) *	2006-12-22	2016-04-27	Astex治疗学有限公司	作为fgfr抑制剂的双环杂环化合物
JP2010516672A (ja) *	2007-01-22	2010-05-20	アストラゼネカ・アクチエボラーグ	新規なヘテロアリール置換されたイミダゾ［１，２−ａ］ピリジン誘導体
CN102224152B (zh) *	2008-11-20	2014-05-21	健泰科生物技术公司	吡唑并吡啶pi3k抑制剂化合物及使用方法

2013
- 2013-11-26 EP EP13795268.5A patent/EP2925756B1/en not_active Not-in-force
- 2013-11-26 JP JP2015544439A patent/JP6007339B2/ja not_active Expired - Fee Related
- 2013-11-26 BR BR112015008200A patent/BR112015008200A2/pt not_active Application Discontinuation
- 2013-11-26 KR KR1020157014095A patent/KR101735975B1/ko active IP Right Grant
- 2013-11-26 CA CA2884956A patent/CA2884956A1/en not_active Abandoned
- 2013-11-26 MX MX2015006513A patent/MX2015006513A/es unknown
- 2013-11-26 WO PCT/EP2013/074662 patent/WO2014082979A1/en active Application Filing
- 2013-11-26 CN CN201380061898.7A patent/CN104822679B/zh not_active Expired - Fee Related
- 2013-11-26 RU RU2015120651A patent/RU2644949C2/ru not_active IP Right Cessation
2015
- 2015-05-27 US US14/723,061 patent/US9315502B2/en not_active Expired - Fee Related
- 2015-09-08 HK HK15108708.9A patent/HK1208029A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2016500121A (ja)	2016-01-07
WO2014082979A1 (en)	2014-06-05
CN104822679B (zh)	2016-10-19
BR112015008200A2 (pt)	2017-07-04
RU2015120651A (ru)	2017-01-10
EP2925756B1 (en)	2017-02-01
CN104822679A (zh)	2015-08-05
KR101735975B1 (ko)	2017-05-15
US20150259341A1 (en)	2015-09-17
JP6007339B2 (ja)	2016-10-12
EP2925756A1 (en)	2015-10-07
US9315502B2 (en)	2016-04-19
RU2644949C2 (ru)	2018-02-15
CA2884956A1 (en)	2014-06-05
MX2015006513A (es)	2015-08-14
KR20150076250A (ko)	2015-07-06

Publication	Publication Date	Title
HUS2200040I1 (hu)	2022-09-28	Benzimidazol-prolin származékok
HK1212984A1 (zh)	2016-06-24	咪唑並吡啶化合物
IL237126A (en)	2016-12-29	Derivatives in cicadas
ZA201405486B (en)	2015-11-25	Pyridone derivatives
HK1205740A1 (en)	2015-12-24	Pyrrolotriazinone derivatives
HK1205508A1 (en)	2015-12-18	New bicyclicpyridine derivatives
ZA201502175B (en)	2018-05-30	Oxazolidin-2-one-pyrimidine derivatives
RS56703B1 (sr)	2018-03-30	Novi derivati fenil-tetrahidroizokinolina
HK1207371A1 (en)	2016-01-29	Pyrazolopyridine derivatives as ttx-s blockers ttx-s
SG11201404325VA (en)	2014-08-28	Pyrimidooxazocine derivatives as mtor - inhibitors
HK1208029A1 (en)	2016-02-19	Imidazopyridine derivatives
HK1214244A1 (zh)	2016-07-22	咪唑並吡啶衍生物

Legal Events

Date	Code	Title	Description
2021-07-09	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20201122